Literature DB >> 25267904

Zolmitriptan for acute migraine headaches in adults.

Sheena Derry1, R Andrew Moore1, Henry J McQuay1.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of zolmitriptan compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Entities:  

Year:  2010        PMID： 25267904      PMCID： PMC4176633          DOI： 10.1002/14651858.CD008616

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  26 in total

1.  Impact of covert duplicate publication on meta-analysis: a case study.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1997-09-13

Review 2.  Burden of migraine. A review of its socioeconomic impact.

Authors:  G D Solomon; K L Price
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

3.  Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

Authors:  J H Lofland; N E Johnson; A S Batenhorst; D B Nash
Journal:  Arch Intern Med       Date:  1999-04-26

4.  Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

Authors:  Seymour Diamond; Marcelo E Bigal; Stephen Silberstein; Elizabeth Loder; Michael Reed; Richard B Lipton
Journal:  Headache       Date:  2007-03       Impact factor: 5.887

Review 5.  Recent advances in understanding migraine mechanisms, molecules and therapeutics.

Authors:  Peter J Goadsby
Journal:  Trends Mol Med       Date:  2006-12-01       Impact factor: 11.951

6.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

7.  Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Authors:  M D Ferrari; P J Goadsby; K I Roon; R B Lipton
Journal:  Cephalalgia       Date:  2002-10       Impact factor: 6.292

8.  Prevalence and burden of headache and migraine in Germany.

Authors:  Andrea Radtke; Hannelore Neuhauser
Journal:  Headache       Date:  2009-01       Impact factor: 5.887

9.  Improvements in health-related quality of life with sumatriptan treatment for migraine.

Authors:  P Jhingran; R K Cady; J Rubino; D Miller; R B Grice; D L Gutterman
Journal:  J Fam Pract       Date:  1996-01       Impact factor: 0.493

10.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.